Novartis and its Novartis Vaccines Diagnostics Inc. unit lodged a complaint Tuesday in the U.S. District Court for the District of Columbia seeking extensions on the patents ranging from five to 435 days.
In addition, the Swiss drug and diagnostics company Roche has a unit that sells a third brand of sequencing machines, although this is a relatively small portion of its revenues.